{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:21:06Z","timestamp":1792797666664,"version":"4.5.0"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["2017\/14880\u22123"],"award-info":[{"award-number":["2017\/14880\u22123"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["2017\/14880\u22123"],"award-info":[{"award-number":["2017\/14880\u22123"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/14880\u22123"],"award-info":[{"award-number":["2017\/14880\u22123"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/14880\u22123"],"award-info":[{"award-number":["2017\/14880\u22123"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.critrevonc.2021.103237","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T11:55:16Z","timestamp":1611316516000},"page":"103237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"special_numbering":"C","title":["Extranodal NK\/T cell lymphoma, nasal type: An updated overview"],"prefix":"10.1016","volume":"159","author":[{"given":"Celeste","family":"S\u00e1nchez-Romero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronell","family":"Bologna-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oslei","family":"Paes de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan Roger","family":"Santos-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"Prado-Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds Bianca","family":"Brand\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rom\u00e1n","family":"Carlos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2021.103237_bib0005","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hon.2533","article-title":"Systemic treatment of a patient with relapsed and refractory extranodal NK\/T-cell lymphoma (ENKL) and meningeosis leukemica with daratumumab","volume":"36","author":"Aeppli","year":"2018","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0010","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2141.2011.08982.x","article-title":"Racial patterns of extranodal natural killer\/T-cell lymphoma, nasal type, in California: a population-based study","volume":"156","author":"Ai","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0015","doi-asserted-by":"crossref","first-page":"934","DOI":"10.12659\/AJCR.899922","article-title":"Nasal type extranodal natural killer\/T (NK\/T) cell lymphoma presenting as periorbital cellulitis: a case report","volume":"17","author":"Al Shawabkeh","year":"2016","journal-title":"Am. J. Case Rep."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0020","series-title":"Immigrants in Texas. Fact Sheet","author":"American Immigration Council","year":"2017"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0025","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00000478-199304000-00010","article-title":"Nasal lymphomas in Peru: high incidence of T-cell immunophenotype and Epstein-Barr virus infection","volume":"17","author":"Arber","year":"1993","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.beha.2013.04.002","article-title":"Epstein-Barr virus-associated natural killer\/T-cell lymphomas","volume":"26","author":"Asano","year":"2013","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0035","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/annonc\/mdi037","article-title":"Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: A single center experience of 10 years","volume":"16","author":"Au","year":"2005","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0040","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0045","doi-asserted-by":"crossref","first-page":"e2015052","DOI":"10.4084\/mjhid.2015.052","article-title":"Nasal NK\/T-Cell lymphoma. A comparative analysis of a Mexican population with the other populations of Latin-America","volume":"7","author":"Avil\u00e8s","year":"2015","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0050","first-page":"38","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru","volume":"15","author":"Barrionuevo","year":"2007","journal-title":"Appl. Immunohistochem. Mol. Morphol. AIMM"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0055","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12288-014-0363-7","article-title":"Nasal natural Killer\/T cell lymphoma","volume":"30","author":"Bhatkule","year":"2014","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0060","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1590\/abd1806-4841.20177232","article-title":"Case for diagnosis. Palate perforation due to cocaine use","volume":"92","author":"Blanco","year":"2017","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0065","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1200\/JCO.2013.51.5304","article-title":"Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins","volume":"32","author":"Bollard","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0070","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1182\/blood.V82.3.858.858","article-title":"Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin\u2019s lymphoma of the midline granuloma type","volume":"82","author":"Borisch","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0075","first-page":"141","article-title":"Nasal NK\/T-cell lymphoma: about two rare cases","volume":"30","author":"Bouayad","year":"2018","journal-title":"Pan Afr. Med. J."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0080","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3109\/10428194.2014.939967","article-title":"Classification of non-Hodgkin lymphoma in Algeria according to the World Health Organization classification","volume":"56","author":"Boudjerra","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0085","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/000348945406300203","article-title":"Lethal granuloma of the midline facial tissues; granuloma gangraenescens","volume":"63","author":"Breckenridge","year":"1954","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0090","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/jayao.2016.0050","article-title":"Delayed diagnosis of a nasal type lymphoma misdiagnosed as persistent sinusitis","volume":"6","author":"Celentano","year":"2017","journal-title":"J. Adolesc. Young Adult Oncol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00277-017-3127-2","article-title":"PD1 blockade with low-dose nivolumab in NK\/T cell lymphoma failing l-asparaginase: efficacy and safety","volume":"97","author":"Chan","year":"2018","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/10428190601016167","article-title":"CD52 expression in non-mycotic T- and NK\/T-cell lymphomas","volume":"48","author":"Chang","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0105","first-page":"1275","article-title":"Lymphoma associated hemophagocytic syndrome: A single-center retrospective study","volume":"16","author":"Chang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0110","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1182\/blood-2014-07-588970","article-title":"Receptor-type tyrosine-protein phosphatase kappa directly targets STAT3 activation for tumor suppression in nasal NK\/T-cell lymphoma","volume":"125","author":"Chen","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0115","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1002\/cam4.1849","article-title":"Risk-dependent curability of radiotherapy for elderly patients with early-stage extranodal nasal-type NK\/T-cell lymphoma: a multicenter study from the China Lymphoma Collaborative Group (CLCG)","volume":"7","author":"Chen","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0120","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s12885-015-1506-4","article-title":"LTA + 252A & G polymorphism is associated with risk of nasal NK\/T-cell lymphoma in a Chinese population: a case-control study","volume":"15","author":"Cheng","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0125","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","article-title":"Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0130","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/mt.2015.91","article-title":"Long-term outcome of extranodal NK\/T cell lymphoma patients treated with postremission therapy using EBV LMP1 and LMP2a-specific CTLs","volume":"23","author":"Cho","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0135","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2133.2008.08922.x","article-title":"Extranodal NK\/T-cell lymphoma with cutaneous involvement: \u201cNasal\u201d vs. \u201cnasal-type\u201d subgroups - A retrospective study of 18 patients","volume":"160","author":"Choi","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0140","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/leu.2009.91","article-title":"STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK \/ T-cell lymphoma","volume":"23","author":"Coppo","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13045-019-0716-7","article-title":"Molecular pathogenic pathways in extranodal NK\/T cell lymphoma","volume":"12","author":"de Mel","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0150","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/ijd.13921","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type, in Senegal","volume":"57","author":"Diallo","year":"2018","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0155","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/gcc.22348","article-title":"Frequent BCOR aberrations in extranodal NK\/T-Cell lymphoma, nasal type","volume":"55","author":"Dobashi","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0160","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.3109\/10428194.2015.1108415","article-title":"Sequential DICE combined with l-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK\/T-cell lymphoma","volume":"57","author":"Dong","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0165","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/lary.25111","article-title":"A comparative population-based analysis of sinonasal diffuse large B-cell and extranodal NK\/T-cell lymphomas","volume":"125","author":"Dubal","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0170","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0002-9610(66)90328-X","article-title":"Primary lymphoma of the nose including a relationship to lethal midline granuloma","volume":"112","author":"Eichel","year":"1966","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0175","series-title":"WHO Classification of Head and Neck Tumours","author":"El-Naggar","year":"2017"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0180","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00005792-199207000-00001","article-title":"Centrofacial malignant granulomas. Clinicopathologic study of 40 cases and review of the literature","volume":"71","author":"Grange","year":"1992","journal-title":"Med. (Baltimore)"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0185","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/PAS.0b013e31821ec4b5","article-title":"Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK\/T-cell lymphoma, nasal type, with EBV subtyping analysis","volume":"35","author":"Gualco","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/pin.12166","article-title":"Activated Janus Kinase 3 expression not by activating mutations identified in Natural Killer\/T-cell lymphoma","volume":"64","author":"Guo","year":"2014","journal-title":"Pathol. Int."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5005\/jp-journals-10013-1185","article-title":"NK\/T-cell lymphoma: a nasal nightmare","volume":"7","author":"Gupta","year":"2014","journal-title":"Clin Rhinol An Int J"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0200","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.arcped.2003.07.005","article-title":"Nasal angiocentric T cell-natural killer cell lymphoma with pancreatic localisation in a child","volume":"10","author":"Hamzaoui","year":"2003","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0205","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0140-6736(90)90002-M","article-title":"Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma","volume":"335","author":"Harabuchi","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0210","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJMc1605684","article-title":"Targeting CD38 in refractory extranodal natural killer cell\u2013T-Cell lymphoma","volume":"375","author":"Hari","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0215","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11899-016-0355-9","article-title":"Extranodal NK\/T cell lymphoma, nasal type (ENKTL-NT): an update on epidemiology, clinical presentation, and natural history in north American and European cases","volume":"11","author":"Haverkos","year":"2016","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0220","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","article-title":"Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type","volume":"115","author":"Huang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0225","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.beha.2013.04.006","article-title":"Molecular underpinning of extranodal NK\/T-cell lymphoma","volume":"26","author":"Huang","year":"2013","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0230","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijrobp.2007.05.073","article-title":"Early or up-front radiotherapy improved survival of localized extranodal NK\/T-Cell lymphoma, Nasal-Type in the upper aerodigestive tract","volume":"70","author":"Huang","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0235","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/ajcp\/aqv010","article-title":"Extranodal natural Killer\/T-Cell lymphoma in children and adolescents: a report of 17 cases in China","volume":"145","author":"Huang","year":"2016","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0240","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2009.3","article-title":"Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies","volume":"23","author":"Iqbal","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0245","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1002\/1097-0142(19821201)50:11<2336::AID-CNCR2820501120>3.0.CO;2-C","article-title":"Nasal T-cell lymphoma as a type of so-called \u201clethal midline granuloma\u201d","volume":"50","author":"Ishii","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0250","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/cncr.21656","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters","volume":"106","author":"Isobe","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0255","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1182\/blood-2010-09-307454","article-title":"Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK\/T-cell lymphoma, a phase 2 study","volume":"117","author":"Jaccard","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0260","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/07357908409040316","article-title":"Pathologic and clinical spectrum of post-thymic t-cell malignancies","volume":"2","author":"Jaffe","year":"1984","journal-title":"Cancer Invest."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0265","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00000478-199601000-00012","article-title":"Report of the workshop on nasal and related extranodal angiocentric T\/natural killer cell lymphomas: definitions, differential diagnosis, and epidemiology","volume":"20","author":"Jaffe","year":"1996","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0270","volume":"vol. 3","author":"Jaffe","year":"2001"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0275","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.bbmt.2018.07.034","article-title":"Allogeneic stem cell transplantation for patients with natural Killer\/T cell lymphoid malignancy: a multicenter analysis comparing upfront and salvage transplantation","volume":"24","author":"Jeong","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0280","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13000-015-0333-x","article-title":"Aggressive natural killer-cell neoplasm presenting in the marrow: a report of two cases including one with gains of chromosomes 4q and 9p","volume":"10","author":"Jhuang","year":"2015","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0285","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.humpath.2014.11.008","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors","volume":"46","author":"Jhuang","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0290","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s00277-016-2805-9","article-title":"Clinical features and survival of extranodal natural killer\/T cell lymphoma with and without hemophagocytic syndrome","volume":"95","author":"Jia","year":"2016","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0295","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ng.3358","article-title":"Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma","volume":"47","author":"Jiang","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0300","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00277-016-2818-4","article-title":"Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK\/T-cell lymphoma, nasal type","volume":"96","author":"Jo","year":"2017","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0305","article-title":"Allogeneic haematopoietic cell transplantation for extranodal natural killer\/T-cell lymphoma, nasal type: a CIBMTR analysis","author":"Kanate","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0310","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1182\/blood-2011-04-346890","article-title":"Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses","volume":"118","author":"Karube","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0315","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/1097-0142(196904)23:4<920::AID-CNCR2820230430>3.0.CO;2-M","article-title":"Midline malignant reticulosis (so-called lethal midline granuloma)","volume":"23","author":"Kassel","year":"1969","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0320","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/hon.2482","article-title":"Frequent expression of CD30 in extranodal NK\/T-cell lymphoma: potential therapeutic target for anti-CD30 antibody-based therapy","volume":"36","author":"Kawamoto","year":"2018","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0325","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1200\/JCO.2009.23.8592","article-title":"Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK\/T-Cell Lymphoma: consortium for improving survival of lymphoma study","volume":"27","author":"Kim","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0330","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00277-014-2137-6","article-title":"Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK\/T cell lymphoma: CISL08-01 phase II study","volume":"93","author":"Kim","year":"2014","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0335","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/S2352-3026(15)00002-2","article-title":"Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer\/T-cell lymphoma, nasal type: a multicentre, retrospective analysis","volume":"2","author":"Kim","year":"2015","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0340","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3109\/10428194.2014.974048","article-title":"Prognostic implications of CD30 expression in extranodal natural killer\/T-cell lymphoma according to treatment modalities","volume":"56","author":"Kim","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0345","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1470-2045(15)00533-1","article-title":"A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis","volume":"17","author":"Kim","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0350","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/978-981-10-7230-7_21","article-title":"EBV in t-\/NK-Cell tumorigenesis","volume":"1045","author":"Kimura","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0355","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/10428194.2013.819577","article-title":"Rare occurrence of JAK3 mutations in natural killer cell neoplasms in Japan","volume":"55","author":"Kimura","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0360","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1182\/blood-2005-06-2569","article-title":"IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines","volume":"107","author":"Kis","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0365","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2559.2004.01867.x","article-title":"NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status","volume":"44","author":"Ko","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0370","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/1096-8652(200102)66:2<145::AID-AJH1033>3.0.CO;2-V","article-title":"Familial nasal NK\/T-cell lymphoma and pesticide use","volume":"66","author":"Kojya","year":"2001","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0375","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ajh.23570","article-title":"Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK\/T-cell lymphoma","volume":"89","author":"Komabayashi","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0380","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajpath.2012.09.012","article-title":"HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms","volume":"182","author":"K\u00fc\u00e7\u00fck","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0385","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2012-05-431460","article-title":"SMILE for natural killer\/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group","volume":"120","author":"Kwong","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0390","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/leu.2013.212","article-title":"Quantification of circulating Epstein-Barr virus DNA in NK\/T-cell lymphoma treated with the SMILE protocol: diagnostic and prognostic significance","volume":"28","author":"Kwong","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0395","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1182\/blood-2016-12-756841","article-title":"PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing L-asparaginase","volume":"129","author":"Kwong","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0400","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/annonc\/mdx684","article-title":"Sequential chemotherapy\/radiotherapy was comparable with concurrent chemoradiotherapy for stage I\/II NK\/T-cell lymphoma","volume":"29","author":"Kwong","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0405","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1182\/blood-2012-07-440073","article-title":"Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases","volume":"120","author":"Laurini","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0410","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","article-title":"Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study","volume":"24","author":"Lee","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0415","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1158\/1078-0432.CCR-06-2373","article-title":"Effect of positive bone marrow EBV in situ hybridization in staging and survival of localized extranodal natural killer\/T-cell lymphoma, nasal-type","volume":"13","author":"Lee","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0420","doi-asserted-by":"crossref","first-page":"17764","DOI":"10.18632\/oncotarget.3776","article-title":"Genetic alterations of JAK\/STAT cascade and histone modification in extranodal NK\/T-cell lymphoma nasal type","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0425","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2005.03.2573","article-title":"Radiotherapy as primary treatment for stage IE and IIE nasal natural killer\/T-cell lymphoma","volume":"24","author":"Li","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0430","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e31826731b5","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson cancer center","volume":"37","author":"Li","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0435","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/10428194.2014.905772","article-title":"Aggressive mature natural killer cell neoplasms: report on a series of 12 European patients with emphasis on flow cytometry based immunophenotype and DNA content of neoplastic natural killer cells","volume":"56","author":"Lima","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0440","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/his.12656","article-title":"Pseudoepitheliomatous hyperplasia mimicking invasive squamous cell carcinoma in extranodal natural killer \/ T-cell lymphoma : a report of 34 cases","volume":"67","author":"Ling","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0445","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3109\/15513815.2012.659385","article-title":"Aggressive sinonasal natural killer\/T-cell lymphoma mimicking refractory sinusitis in a 4-year-old boy","volume":"31","author":"Liu","year":"2012","journal-title":"Fetal Pediatr. Pathol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0450","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.hoc.2016.11.007","article-title":"Clinical features and current optimal management of natural Killer\/T-Cell lymphoma","volume":"31","author":"Makita","year":"2017","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0455","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/014556130808701015","article-title":"Angiogenic non-Hodgkin T\/natural killer (NK)-cell lymphoma: report of three cases","volume":"87","author":"Martins-Filho","year":"2008","journal-title":"Ear Nose Throat J."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0460","first-page":"64","article-title":"Photographs of a case of rapid destruction of the nose and face","volume":"12","author":"McBride","year":"1897","journal-title":"J. Laryngol. Otol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0465","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/his.12990","article-title":"Small-cell predominant extranodal NK\/T cell lymphoma, nasal type: clinicopathological analysis of a series of cases diagnosed in a Western population","volume":"69","author":"McKelvie","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0470","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bjorl.2014.05.013","article-title":"Clinical and otorhinolaryngological aspects of extranodal NK\/T cell lymphoma, nasal type","volume":"80","author":"Miyake","year":"2014","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0475","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ajh.20091","article-title":"NK-cell related neoplasms in Osaka","volume":"76","author":"Miyazato","year":"2004","journal-title":"Japan. Am J Hematol"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0480","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1288\/00005537-195104000-00004","article-title":"Idiopathic (lethal) granuloma of the midline facial tissues treated with cortisone: report of a case","volume":"61","author":"Moore","year":"1951","journal-title":"Laryngoscope"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0485","first-page":"2814","article-title":"Daratumumab efficiently targets NK\/T cell lymphoma with high CD38 expression","volume":"130","author":"Mustafa","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0490","series-title":"NCCN Clinical Practice Guidelines in Oncology: T-Cell Lymphomas","author":"National Comprehensive Cancer Network","year":"2020"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0495","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1080\/10428194.2018.1551541","article-title":"Clinical presentation, treatment, and outcomes of patients with central nervous system involvement in extranodal natural killer\/T-cell lymphoma","volume":"60","author":"Nevel","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0500","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00428-001-0545-1","article-title":"Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma - Natural killer cell, cytotoxic T lymphocyte, and non-NK\/CTL types","volume":"440","author":"Ohshima","year":"2002","journal-title":"Virchows Arch."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0505","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1158\/1078-0432.CCR-11-0494","article-title":"MicroRNA-146a downregulates NF\u03baB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK\/T cell lymphoma","volume":"17","author":"Paik","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0510","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7181\/acfs.2016.17.3.165","article-title":"Recurrent extranodal NK\/T-Cell lymphoma presenting as a perforating palatal ulcer and oro-nasal fistula","volume":"17","author":"Park","year":"2016","journal-title":"Arch Craniofacial Surg"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0515","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12105-018-0910-x","article-title":"Oral manifestation of lymphomatoid granulomatosis","volume":"13","author":"Pereira","year":"2019","journal-title":"Head Neck Pathol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0520","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3109\/10428194.2011.584254","article-title":"Classification of non-Hodgkin lymphomas in Guatemala according to the World Health Organization system","volume":"52","author":"Perry","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0525","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/bjh.14044","article-title":"Mature T- and NK-cell non-Hodgkin lymphoma in children and young adolescents","volume":"173","author":"Pillai","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0530","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/PAS.0b013e31824433d8","article-title":"Extranodal NK\/T-cell lymphoma, nasal type, includes cases of natural killer cell and \u03b1\u03b2, \u03b3\u03b4, and \u03b1\u03b2\/\u03b3\u03b4 T-cell origin: A comprehensive clinicopathologic and phenotypic study","volume":"36","author":"Pongpruttipan","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0535","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1590\/0103-6440201302202","article-title":"Extranodal nasal NK\/T-cell lymphoma: a rare oral presentation and FASN, CD44 and GLUT-1 expression","volume":"24","author":"Pontes","year":"2013","journal-title":"Braz. Dent. J."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0540","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1080\/10428194.2019.1599111","article-title":"Upfront radiation is essential for high-risk early-stage extranodal NK\/T-cell lymphoma, nasal type: comparison of two sequential treatment modalities combining radiotherapy and GDP (gemcitabine, dexamethasone, and cisplatin) in the modern era","volume":"60","author":"Qi","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0545","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0002-9440(10)63061-1","article-title":"p53 Mutations in nasal natural killer\/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease","volume":"159","author":"Quintanilla-Martinez","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0550","doi-asserted-by":"crossref","first-page":"aab3884","DOI":"10.1126\/science.aab3884","article-title":"POPULATION GENETICS. Genomic evidence for the Pleistocene and recent population history of Native Americans","volume":"349","author":"Raghavan","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0555","first-page":"1","article-title":"Extranodal NK\/T-Cell lymphoma, nasal type, presenting as refractory Pseudomonas aeruginosa facial cellulitis","volume":"5","author":"Reategui Schwarz","year":"2017","journal-title":"J. Investig. Med. High Impact Case Reports"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0560","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1001\/archinte.1959.00270010122016","article-title":"Lethal midline granuloma of the face: report of case and review of the literature","volume":"103","author":"Resnick","year":"1959","journal-title":"AMA Arch. Intern. Med."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0565","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1684\/ejd.2017.3205","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type: a Spanish multicentric retrospective survey","volume":"28","author":"Rozas-Mu\u00f1oz","year":"2018","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0570","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s12105-019-01027-z","article-title":"Extranodal NK\/T-Cell lymphoma, nasal type in Guatemala: an 86-case series emphasizing clinical presentation and microscopic characteristics","volume":"13","author":"S\u00e1nchez-Romero","year":"2019","journal-title":"Head Neck Pathol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0575","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3109\/10428194.2014.894188","article-title":"Extranodal natural killer\/T cell lymphomas with extranasal disease in non-endemic regions are disseminated or have nasal primary: a study of 84 cases from India","volume":"55","author":"Shet","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0580","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0360-3016(01)01800-4","article-title":"Localized aggressive non-Hodgkin\u2019s lymphoma of the nasal cavity: a survey by the Japan lymphoma radiation therapy group","volume":"51","author":"Shikama","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0585","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1017\/S0022215100039359","article-title":"Progressive lethal granulomatous ulceration of the nose","volume":"48","author":"Stewart","year":"1933","journal-title":"J. Laryngol. Otol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0590","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/ejh.13126","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: Clinical features, outcome, and prognostic factors in 101 cases","volume":"101","author":"Su","year":"2018","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0595","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11899-018-0430-5","article-title":"NK\/T cell lymphoma: updates in therapy","volume":"13","author":"Suzuki","year":"2018","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0600","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1182\/blood.V83.8.2255.2255","article-title":"Expression of adult and fetal natural killer cell markers in sinonasal lymphomas","volume":"83","author":"Suzumiya","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0605","series-title":"World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0610","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.anorl.2011.08.004","article-title":"Extranodal NK \/ T-cell lymphoma, nasal type: report of 15 cases Lymphome T \/ NK nasal","volume":"129","author":"Tababi","year":"2012","journal-title":"\u00c0 propos de 15 cas. Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0615","article-title":"EBV induces persistent NF-\u03baB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells","volume":"12","author":"Takada","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0620","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.5353.5353","article-title":"A phase II study of bortezomib-GIFOX (Gemcitabine, Ifosfamide, Oxaliplatin) in patients with newly diagnosed natural-killer\/T-Cell lymphoma","volume":"128","author":"Tang","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0625","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1746-160X-9-4","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type: \u201cmidline lethal granuloma.\u201d A case report","volume":"9","author":"Tlholoe","year":"2013","journal-title":"Head Face Med."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0630","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1186\/s12885-017-3612-y","article-title":"Extranodal natural killer\/T-cell lymphoma in Malawi: a report of three cases","volume":"17","author":"Tomoka","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0635","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1182\/blood-2013-01-453233","article-title":"How I treat NK\/T-cell lymphomas","volume":"121","author":"Tse","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0640","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1182\/blood-2015-07-655191","article-title":"Nasal NK\/T-cell lymphoma: RT, CT, or both","volume":"126","author":"Tse","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0645","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/17474086.2016.1206465","article-title":"Diagnosis and management of extranodal NK\/T cell lymphoma nasal type","volume":"9","author":"Tse","year":"2016","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0650","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13045-017-0452-9","article-title":"The diagnosis and management of NK\/T-cell lymphomas","volume":"10","author":"Tse","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0655","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.beha.2019.06.005","article-title":"NK\/T-cell lymphomas","volume":"32","author":"Tse","year":"2019","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0660","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0046-8177(97)90158-1","article-title":"Extranodal head and neck lymphomas in Guatemala: high frequency of Epstein-Barr virus-associated sinonasal lymphomas","volume":"28","author":"van de Rijn","year":"1997","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0665","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1002\/cncr.30697","article-title":"The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T-cell lymphoma, nasal type, in the United States","volume":"123","author":"Vargo","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0670","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/10428190601059795","article-title":"Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity","volume":"48","author":"Wang","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0675","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood-2009-07-235853","article-title":"Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK \/ T-cell lymphoma in children and adolescents","volume":"114","author":"Wang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0680","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ijrobp.2011.02.039","article-title":"Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early-stage nasal NK\/T-cell lymphoma","volume":"82","author":"Wang","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0685","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/cncr.27752","article-title":"First-line combination of gemcitabine, oxaliplatin, and L-asparaginase (GELOX) followed by involved-field radiation therapy for patients with stage IE\/IIE extranodal natural killer\/T-cell lymphoma","volume":"119","author":"Wang","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0690","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00277-015-2359-2","article-title":"CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK\/T cell lymphoma, nasal type","volume":"94","author":"Wang","year":"2015","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0695","doi-asserted-by":"crossref","DOI":"10.1007\/s00432-019-02957-5","article-title":"PET \/ CT \u2011 based bone \u2011 marrow assessment shows potential in replacing routine bone \u2011 marrow biopsy in part of patients newly diagnosed with extranodal natural killer \/ T \u2011 cell lymphoma","author":"Wang","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0700","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1309\/E5PR-6A9R-Q02N-8QVW","article-title":"Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon","volume":"115","author":"Wong","year":"2001","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0705","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/bmj.2.3159.65","article-title":"Observations on malignant granuloma of the nose","volume":"2","author":"Woods","year":"1921","journal-title":"Br. Med. J."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0710","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.clon.2008.05.011","article-title":"A clinical study of 115 patients with extranodal natural Killer\/T-cell lymphoma, nasal type","volume":"20","author":"Wu","year":"2008","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0715","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ijc.22313","article-title":"Life-style and environmental factors in the development of nasal NK\/T-cell lymphoma: a case-control study in East Asia","volume":"120","author":"Xu","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0720","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1","article-title":"Frequent expression of P\u2010glycoprotein\/MDR1 by nasal T\u2010cell lymphoma cells","volume":"76","author":"Yamaguchi","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0725","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1200\/JCO.2009.23.8295","article-title":"Phase I\/II study of concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: japan clinical oncology group study JCOG0211","volume":"27","author":"Yamaguchi","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0730","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","article-title":"Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study","volume":"29","author":"Yamaguchi","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0735","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1200\/JCO.2012.45.6541","article-title":"Concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211","volume":"30","author":"Yamaguchi","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0740","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1182\/blood-2017-12-791418","article-title":"Advances in the treatment of extranodal NK\/T-cell lymphoma, nasal type","volume":"131","author":"Yamaguchi","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0745","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.beha.2018.07.002","article-title":"Extranodal NK\/T-cell lymphoma: updates in biology and management strategies","volume":"31","author":"Yamaguchi","year":"2018","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0750","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1200\/JCO.2016.68.1619","article-title":"Treatments and outcomes of patients with extranodal natural Killer\/T-Cell lymphoma diagnosed between 2000 and 2013: a cooperative study in Japan","volume":"35","author":"Yamaguchi","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0755","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1746-1596-6-77","article-title":"Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution","volume":"6","author":"Yang","year":"2011","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0760","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood-2015-04-639336","article-title":"Risk-adapted therapy for early-stage extranodal nasal-type NK\/T-cell lymphoma: analysis from a multicenter study","volume":"126","author":"Yang","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103237_bib0765","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.bbmt.2015.05.003","article-title":"Clinical outcomes and prognostic factors of up-front autologous stem cell transplantation in patients with extranodal natural Killer\/T cell lymphoma","volume":"21","author":"Yhim","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0770","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1046\/j.1365-2141.2003.04359.x","article-title":"Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T\/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions","volume":"121","author":"Zhang","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0775","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/cam4.569","article-title":"Five-year analysis from phase 2 trial of \u201csandwich\u201d chemoradiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer\/T-cell lymphoma","volume":"5","author":"Zhang","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.critrevonc.2021.103237_bib0780","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/cjp2.114","article-title":"High frequency of CD74 expression in lymphomas: implications for targeted therapy using a novel anti-CD74-drug conjugate","volume":"5","author":"Zhao","year":"2019","journal-title":"J. Pathol. Clin. Res."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842821000251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842821000251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:38:31Z","timestamp":1760902711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842821000251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":156,"alternative-id":["S1040842821000251"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103237","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extranodal NK\/T cell lymphoma, nasal type: An updated overview","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103237"}}